| 1AK4 | A:1-165; B:3-165 | HUMAN CYCLOPHILIN A BOUND TO THE AMINO-TERMINAL DOMAIN OF HIV-1 CAPSID |
| 1AWQ | A:1002-1165 | CYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER) |
| 1AWR | A:1002-1165; C:1002-1165; D:1002-1165; E:1002-1165; F:1002-1165; B:1002-1165 | CYPA COMPLEXED WITH HAGPIA |
| 1AWS | A:1002-1165 | SECYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER) |
| 1AWT | A:1002-1165; B:1002-1165; C:1002-1165; D:1002-1165; E:1002-1165; F:1002-1165 | SECYPA COMPLEXED WITH HAGPIA |
| 1AWU | A:1002-1165 | CYPA COMPLEXED WITH HVGPIA (PSEUDO-SYMMETRIC MONOMER) |
| 1AWV | A:1002-1165; B:1002-1165; C:1002-1165; D:1002-1165; E:1002-1165; F:1002-1165 | CYPA COMPLEXED WITH HVGPIA |
| 1BCK | A:1-165 | HUMAN CYCLOPHILIN A COMPLEXED WITH 2-THR CYCLOSPORIN |
| 1CWA | A:1-165 | X-RAY STRUCTURE OF A MONOMERIC CYCLOPHILIN A-CYCLOSPORIN A CRYSTAL COMPLEX AT 2.1 ANGSTROMS RESOLUTION |
| 1CWB | A:1-165 | THE X-RAY STRUCTURE OF (MEBM2T)1-CYCLOSPORIN COMPLEXED WITH CYCLOPHILIN A PROVIDES AN EXPLANATION FOR ITS ANOMALOUSLY HIGH IMMUNOSUPPRESSIVE ACTIVITY |
| 1CWC | A:1-165 | IMPROVED BINDING AFFINITY FOR CYCLOPHILIN A BY A CYCLOSPORIN DERIVATIVE SINGLY MODIFIED AT ITS EFFECTOR DOMAIN |
| 1CWF | A:1-165 | HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL CYCLOSPORIN |
| 1CWH | A:1-165 | HUMAN CYCLOPHILIN A COMPLEXED WITH 3-D-SER CYCLOSPORIN |
| 1CWI | A:1-165 | HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-(N-METHYL)-D-ALANINE CYCLOSPORIN |
| 1CWJ | A:1-165 | HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-S-METHYL-SARCOSINE CYCLOSPORIN |
| 1CWK | A:1-165 | HUMAN CYCLOPHILIN A COMPLEXED WITH 1-(6,7-DIHYDRO)MEBMT 2-VAL 3-D-(2-S-METHYL)SARCOSINE CYCLOSPORIN |
| 1CWL | A:1-165 | HUMAN CYCLOPHILIN A COMPLEXED WITH 4 4-HYDROXY-MELEU CYCLOSPORIN |
| 1CWM | A:1-165 | HUMAN CYCLOPHILIN A COMPLEXED WITH 4 MEILE CYCLOSPORIN |
| 1CWO | A:1-165 | HUMAN CYCLOPHILIN A COMPLEXED WITH THR2, LEU5, D-HIV8, LEU10 CYCLOSPORIN |
| 1CYN | A:7-184 | CYCLOPHILIN B COMPLEXED WITH [D-(CHOLINYLESTER)SER8]-CYCLOSPORIN |
| 1FGL | A:1-165 | CYCLOPHILIN A COMPLEXED WITH A FRAGMENT OF HIV-1 GAG PROTEIN |
| 1M63 | C:1-165; G:1-165 | CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN SHOWS COMMON BUT DISTINCT RECOGNITION OF IMMUNOPHILIN-DRUG COMPLEXES |
| 1M9C | A:1-165; B:3-165 | X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE COMPLEX. |
| 1M9D | A:1-165; B:3-165 | X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) O-TYPE CHIMERA COMPLEX. |
| 1M9E | A:1-164; B:3-164 | X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE H87A COMPLEX. |
| 1M9F | A:1-165; B:2-165 | X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE H87A,A88M COMPLEX. |
| 1M9X | A:1-165; E:1-165; B:2-165; F:2-165 | X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE H87A,A88M,G89A COMPLEX. |
| 1M9Y | A:1-165; E:1-165; B:2-165; F:2-165 | X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N-TERMINAL DOMAIN (1-146) M-TYPE H87A,G89A COMPLEX. |
| 1MF8 | C:1-164 | CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH CYCLOSPORIN A AND HUMAN CYCLOPHILIN |
| 1MIK | A:1-165 | THE ROLE OF WATER MOLECULES IN THE STRUCTURE-BASED DESIGN OF (5-HYDROXYNORVALINE)-2-CYCLOSPORIN: SYNTHESIS, BIOLOGICAL ACTIVITY, AND CRYSTALLOGRAPHIC ANALYSIS WITH CYCLOPHILIN A |
| 1MZW | A:5-177 | CRYSTAL STRUCTURE OF A U4/U6 SNRNP COMPLEX BETWEEN HUMAN SPLICEOSOMAL CYCLOPHILIN H AND A U4/U6-60K PEPTIDE |
| 1NMK | A:1-165; B:1-165 | THE SANGLIFEHRIN-CYCLOPHILIN INTERACTION: DEGRADATION WORK, SYNTHETIC MACROCYCLIC ANALOGUES, X-RAY CRYSTAL STRUCTURE AND BINDING DATA |
| 1OCA | A:1-165 | HUMAN CYCLOPHILIN A, UNLIGATED, NMR, 20 STRUCTURES |
| 1QOI | A:5-177 | U4/U6 SNRNP-SPECIFIC CYCLOPHILIN SNUCYP-20 |
| 1RMH | A:2-165; B:2-165 | RECOMBINANT CYCLOPHILIN A FROM HUMAN T CELL |
| 1VBS | A:2-165 | STRUCTURE OF CYCLOPHILIN COMPLEXED WITH (D)ALA CONTAINING TETRAPEPTIDE |
| 1VBT | A:2-165; B:2-165 | STRUCTURE OF CYCLOPHILIN COMPLEXED WITH SULFUR-SUBSTITUTED TETRAPEPTIDE AAPF |
| 1W8L | A:1-165 | ENZYMATIC AND STRUCTURAL CHARACTERIZATION OF NON PEPTIDE LIGAND CYCLOPHILIN COMPLEXES |
| 1W8M | A:1-165 | ENZYMATIC AND STRUCTURAL CHARACTERISATION OF NON PEPTIDE LIGAND CYCLOPHILIN COMPLEXES |
| 1W8V | A:1-165 | ENZYMATIC AND STRUCTURAL CHARACTERIZATION OF NON PEPTIDE LIGAND CYCLOPHILIN COMPLEXES |
| 1XWN | A:1-166 | SOLUTION STRUCTURE OF CYCLOPHILIN LIKE 1(PPIL1) AND INSIGHTS INTO ITS INTERACTION WITH SKIP |
| 1XYH | A:1-160 | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN CYCLOPHILIN J |
| 1YND | A:2-165; B:2-165 | STRUCTURE OF HUMAN CYCLOPHILIN A IN COMPLEX WITH THE NOVEL IMMUNOSUPPRESSANT SANGLIFEHRIN A AT 1.6A RESOLUTION |
| 1ZKC | B:279-438; A:271-457 | CRYSTAL STRUCTURE OF THE CYCLOPHILN_RING DOMAIN OF HUMAN PEPTIDYLPROLYL ISOMERASE (CYCLOPHILIN)-LIKE 2 ISOFORM B |
| 1ZKF | A:1-165; B:2-165 | CYRSTAL STRUCTURE OF HUMAN CYCLOPHILIN-A IN COMPLEX WITH SUC-AGPF-PNA |
| 1ZMF | A:139-300 | C DOMAIN OF HUMAN CYCLOPHILIN-33(HCYP33) |
| 2A2N | C:482-646; A:483-646; B:483-646 | CRYSTAL STRUCTURE OF THE PEPTIDYLPROLYL ISOMERASE DOMAIN OF HUMAN PPWD1 |
| 2ALF | A:2-165 | CRYSTAL STRUCTURE OF HUMAN CYPA MUTANT K131A |
| 2BIT | X:2-165 | CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D AT 1.7 A RESOLUTION |
| 2BIU | X:2-165 | CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D AT 1.7 A RESOLUTION, DMSO COMPLEX |
| 2CPL | A:2-165 | SIMILARITIES AND DIFFERENCES BETWEEN HUMAN CYCLOPHILIN A AND OTHER BETA-BARREL STRUCTURES. STRUCTURAL REFINEMENT AT 1.63 ANGSTROMS RESOLUTION |
| 2CYH | A:2-165 | CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE ALA-PRO |
| 2ESL | A:32-212; B:32-212; C:32-212; D:32-212; E:32-212; F:32-212 | HUMAN CYCLOPHILIN C IN COMPLEX WITH CYCLOSPORIN A |
| 2R99 | A:138-301 | CRYSTAL STRUCTURE OF CYCLOPHILIN ABH-LIKE DOMAIN OF HUMAN PEPTIDYLPROLYL ISOMERASE E ISOFORM 1 |
| 3CYH | A:2-165 | CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE SER-PRO |
| 3CYS | A:1-165 | DETERMINATION OF THE NMR SOLUTION STRUCTURE OF THE CYCLOPHILIN A-CYCLOSPORIN A COMPLEX |
| 4CYH | A:2-165 | CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE HIS-PRO |
| 5CYH | A:2-165 | CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE GLY-PRO |
)
)